Holland & Barrett has announced its results for the financial year ended 30 September 2024, with 10% year-on-year sales growth and a gross profit totalling £524.2 million.

The retail leader credits this performance to its  continuing ‘customer-first strategy’ and a significant transformation strategy aimed at meeting growing demand in the wellness and preventative health space.

Alex Gourlay, executive chair of Holland & Barrett said: “This has been a landmark year for our business – one defined by purpose, transformation and a significant investment in the future of this 150-year-old business. With societal shifts towards prevention, testing and self-care, and insufficient public health care provision due to constraints on national health systems, there is an increasing unmet need which Holland & Barrett was well positioned to serve. It is with great pride, that we have taken the bold steps necessary to meet the evolving needs of our customers, accelerating our transformation journey and laying a strong foundation for long-term growth.”

Commenting on the latest results, he added: “Our retail performance continues to outperform the UK and Netherlands high streets and compares strongly against other European countries. We are energised by the momentum we’ve built and excited for the opportunities ahead. I could not be happier with the ongoing performance of the business or prouder of our colleagues who have been at the heart of delivering this strong growth.”

Holland & Barrett has already seen strong growth carry on into H1 of FY25, with sales and gross profit both up 8% year-on-year and customer numbers and satisfaction continuing to grow. As a result, the company is confident ti will see a third consecutive year of strong growth, driven by the significant acceleration of online in FY25. 

Read Holland & Barrett’s Annual Report & Consolidated Financial Results – year ended 30 Sep 2024